Clinical Trials Directory

Trials / Sponsors / Nivalis Therapeutics, Inc.

Nivalis Therapeutics, Inc.

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
CompletedMAD Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Cavosonstat (N91115) in Healthy Subject
Cystic Fibrosis
Phase 12016-10-01
UnknownStudy of Cavosonstat (N91115) in CF Patients Who Are Heterozygous for F508del-CFTR and a Gating Mutation and B
Cystic Fibrosis
Phase 22016-04-01
CompletedStudy of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation
Cystic Fibrosis
Phase 22015-11-01
CompletedA Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects
Drug Interaction Potentiation
Phase 12015-06-01
CompletedStudy of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
Cystic Fibrosis
Phase 12015-02-01
CompletedPK Study of N91115 in Cystic Fibrosis Patients
Cystic Fibrosis
Phase 12014-10-01
CompletedMAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects
Healthy
Phase 12014-02-01
CompletedSafety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mut
Cystic Fibrosis
Phase 12014-02-01
CompletedA Safety Study Evaluating N6022 in Multiple-Ascending Doses in Healthy Subjects
Healthy
Phase 12011-04-01
CompletedStudy to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma
Asthma
Phase 1 / Phase 22011-03-01
CompletedSafety and Tolerability Study of N6022 in Healthy Subjects
Healthy
Phase 12010-08-01